Skip to Main Content

Paper Details

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Blood
25
2021
CD8, CD8+, CD8+ T-cell, CTLA-4, GVL, HLA-DR, ICOS, PD-1, Relapsed myeloid disease, T-cell, T-cell receptor sequences, graft-versus-leukemia, ipilimumab, leukemic, leukemic biopsies, memory T-cell populations, myeloid malignancies, patients
Author NameAffiliation
Seunghee Kim-SchulzeHuman Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai
Seunghee Kim-SchulzeHuman Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai
Stacey GabrielBroad Institute of Massachusetts Institute of Technology and Harvard University
Stacey GabrielBroad Institute of Massachusetts Institute of Technology and Harvard University
Jerome RitzDana-Farber Cancer Institute
Jerome RitzHarvard Medical School
Jerome RitzBrigham and Women's Hospital
Donna NeubergDana-Farber Cancer Institute
Sacha GnjaticHuman Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai
Sacha GnjaticHuman Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai
Xiaole Shirley LiuDana-Farber Cancer Institute
Xiaole Shirley LiuHarvard T.H. Chan School of Public Health
Catherine J WuDana-Farber Cancer Institute
Catherine J WuBroad Institute of Massachusetts Institute of Technology and Harvard University
Catherine J WuHarvard Medical School
Catherine J WuBrigham and Women's Hospital
  • 1 - 16

Datasets

Release 1.2